We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,822
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Gentherm
THRM
$1.28B
| $30.1M | 0.16% |
372,139
-70,875
| -16% | -$5.61M |
|
152
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $29.8M | 0.16% |
768,613
+167,972
| +28% | +$6.59M |
|
|
EVBG
153
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $29.7M | 0.16% |
196,898
+15,895
| +9% | +$2.35M |
|
154
SLM Corp
SLM
$5.09B
| $29.3M | 0.15% |
1,666,285
+3,999
| +0.2% | +$75.1K |
|
155
Zoetis
ZTS
$31.9B
| $29.2M | 0.15% |
150,259
+14,908
| +11% | +$3.01M |
|
156
Equinix
EQIX
$102B
| $29.1M | 0.15% |
36,866
+4,105
| +13% | +$3.41M |
|
157
Netflix
NFLX
$306B
| $28.3M | 0.15% |
462,960
+121,290
| +35% | +$6.67M |
|
|
VPU
158
Vanguard Utilities ETF
VPU
$8.43B
| $28.2M | 0.15% |
202,378
+14,176
| +8% | +$2.07M |
|
159
iShares Core US Aggregate Bond ETF
AGG
$138B
| $28.1M | 0.15% |
244,938
-21,804
| -8% | -$2.53M |
|
160
Integer Holdings
ITGR
$4.23B
| $28M | 0.15% |
313,779
+3,442
| +1% | +$322K |
|
161
Estee Lauder
EL
$31.5B
| $27.8M | 0.15% |
92,605
+13,566
| +17% | +$4.43M |
|
162
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
| $27.7M | 0.15% |
191,761
+16,419
| +9% | +$2.44M |
|
163
iShares MSCI ACWI ETF
ACWI
$33.4B
| $27.6M | 0.15% |
276,643
+92
| +0% | +$9.44K |
|
164
iShares Gold Trust
IAU
$63.3B
| $27.2M | 0.14% |
813,235
+207,598
| +34% | +$7.07M |
|
165
CME Group
CME
$95.7B
| $26.9M | 0.14% |
139,141
+24,887
| +22% | +$5.04M |
|
166
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $26.9M | 0.14% |
179,529
+56,377
| +46% | +$8.63M |
|
167
KT
KT
$8.75B
| $26.6M | 0.14% |
1,954,565
-4,652
| -0.2% | -$65.9K |
|
168
Caterpillar
CAT
$404B
| $26.6M | 0.14% |
138,577
+2,730
| +2% | +$569K |
|
169
Qualcomm
QCOM
$171B
| $26.4M | 0.14% |
204,532
+4,885
| +2% | +$693K |
|
170
FirstCash
FCFS
$9.08B
| $26.3M | 0.14% |
300,428
+836
| +0.3% | +$69.2K |
|
171
IPG Photonics
IPGP
$3.7B
| $26.2M | 0.14% |
165,595
+11,235
| +7% | +$2.06M |
|
172
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.27B
| $26.1M | 0.14% |
373,871
+5,463
| +1% | +$389K |
|
173
Idexx Laboratories
IDXX
$44.8B
| $26.1M | 0.14% |
41,953
-12,244
| -23% | -$8.23M |
|
174
American Water Works
AWK
$26.1B
| $25.8M | 0.14% |
152,428
+10,007
| +7% | +$1.75M |
|
175
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $25.6M | 0.13% |
480,617
+19,646
| +4% | +$1.05M |
|
Similar funds
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,822 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.